Loss of the LAT adaptor converts antigen-responsive T cells into pathogenic effectors that function independently of the T cell receptor. by Mingueneau, M. et al.
Loss of the LAT adaptor converts antigen-responsive T cells into
pathogenic effectors that function independently of the T cell receptor.
Mingueneau, M., Roncagalli, R., Grégoire, C., Kissenpfennig, A., Miazek, A., Archambaud, C., ... Aguado, E.
(2009). Loss of the LAT adaptor converts antigen-responsive T cells into pathogenic effectors that function
independently of the T cell receptor. DOI: 10.1016/j.immuni.2009.05.013
Published in:
Immunity
Document Version:
Publisher's PDF, also known as Version of record
Queen's University Belfast - Research Portal:
Link to publication record in Queen's University Belfast Research Portal
General rights
Copyright for the publications made accessible via the Queen's University Belfast Research Portal is retained by the author(s) and / or other
copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated
with these rights.
Take down policy
The Research Portal is Queen's institutional repository that provides access to Queen's research output. Every effort has been made to
ensure that content in the Research Portal does not infringe any person's rights, or applicable UK laws. If you discover content in the
Research Portal that you believe breaches copyright or violates any law, please contact openaccess@qub.ac.uk.
Download date:09. Sep. 2018
Immunity
ArticleLoss of the LATAdaptor Converts Antigen-Responsive
T Cells into Pathogenic Effectors
that Function Independently of the T Cell Receptor
Michael Mingueneau,1,2,3,5 Romain Roncagalli,1,2,3,5 Claude Gre´goire,1,2,3 Adrien Kissenpfennig,1,2,3,6
Arkadiusz Miazek,1,2,3,7 Cristel Archambaud,1,2,3 Ying Wang,1,2,3,8 Pierre Perrin,1,2,3 Elodie Bertosio,1,2,3
Amandine Sansoni,1,2,3 Sylvie Richelme,1,2,3 Richard M. Locksley,4 Enrique Aguado,1,2,3,9 Marie Malissen,1,2,3
and Bernard Malissen1,2,3,*
1Centre d’Immunologie de Marseille-Luminy, Universite´ de la Me´diterrane´e, Case 906, 13288 Marseille Cedex 9, France
2INSERM, U631, 13288 Marseille Cedex 9, France
3CNRS, UMR6102, 13288 Marseille Cedex 9, France
4Howard Hughes Medical Institute, Department of Medicine and Department of Microbiology and Immunology, University of California,
San Francisco, San Francisco, CA 94143, USA
5These authors contributed equally to this work
6Present address: Centre for Infection and Immunity, School of Medicine, Dentistry and Biomedical Sciences, Queen’s University,
Belfast BT9 7BL, UK
7Present address: Department of Tumor Immunology, Institute of Immunology and Experimental Therapy, Wroclaw 53-114, Poland
8Present address: Shanghai Institute of Immunology, Institute of Medical Science, Shanghai Jiaotong University School of Medicine,
Shanghai 200025, P R of China
9Present address: Hospital Universitario de Puerto Real, Unidad de Investigacio´n, Carretera Nacional IV Km. 665, 11510 Puerto Real,
Ca´diz, Spain
*Correspondence: bernardm@ciml.univ-mrs.fr
DOI 10.1016/j.immuni.2009.05.013SUMMARY
Despite compromised T cell antigen receptor (TCR)
signaling, mice in which tyrosine 136 of the adaptor
linker for activation of T cells (LAT) was constitutively
mutated (LatY136F mice) accumulate CD4+ T cells that
trigger autoimmunity and inflammation. Here we
show that equipping postthymic CD4+ T cells with
LATY136F molecules or rendering them deficient in
LAT molecules triggers a lymphoproliferative dis-
order dependent on prior TCR engagement. There-
fore, such disorders required neither faulty thymic
T cell maturation nor LATY136F molecules. Unex-
pectedly, in CD4+ T cells recently deprived of LAT,
the proximal triggering module of the TCR induced
a spectrum of protein tyrosine phosphorylation that
largely overlapped the one observed in the presence
of LAT. The fact that such LAT-independent signals
result in lymphoproliferative disorders with exces-
sive cytokine production demonstrates that LAT
constitutes a key negative regulator of the triggering
module and of the LAT-independent branches of the
TCR signaling cassette.
INTRODUCTION
After recognition of antigenic peptides bound to major histocom-
patibility complex (MHC) molecules, the tyrosine residues found
in the CD3 chains of the T cell antigen receptor (TCR) complex
are phosphorylated by the Src family kinase Lck. This allowsthe recruitment of the protein tyrosine kinase ZAP-70 that in
turn phosphorylates a number of substrates including the trans-
membrane adaptor protein LAT (linker for activation of T cells).
Upon tyrosine phosphorylation, LAT nucleates the assembly of
a multiprotein complex—the LAT signalosome—that bridges
the T cell-specific and the ubiquitous components of the
signaling pathways that control T cell development and function.
Analysis of T cell lines deficient in LAT and of mice expressing
a null allele of Lat (Lat/) demonstrated that LAT constitutes a
mandatory component of the TCR and pre-TCR signaling
cassettes, respectively (Finco et al., 1998; Zhang et al., 1999a).
Mice in which a phenylalanine replaces a tyrosine at position
136 (Y136) of LAT (LatY136F/Y136F mice) show a severe but incom-
plete block at the checkpoints controlling intrathymic ab T cell
development (Aguado et al., 2002; Sommers et al., 2002). As
a consequence, in 2-week-old LatY136F/Y136F mice, there were
eight times fewer CD4+ T cells in lymph nodes than in wild-
type control mice. However, those few CD4+ T cells expanded
in the absence of any deliberate immunization, leading to
a 5-fold increased number of CD4+ T cells in secondary lymphoid
organs of 6-week-old LatY136F/Y136F mice as compared to wild-
type controls. Moreover, the stable T helper 2 (Th2) effector
phenotype acquired by the expanding LatY136F/Y136F CD4+
T cells triggered a massive polyclonal B cell activation leading
to hypergammaglobulinemia IgG1 and IgE and resulting in auto-
immune nephritis (Genton et al., 2006). In the course of expan-
sion, LatY136F/Y136F CD4+ T cells underwent a conversion into a
state where they became refractory to TCR signals and capable
of providing help to B cells in an MHCII-independent manner
(Wang et al., 2008). LatY136F/Y136F T CD4+ cells manifested no
tropism for the skin and the gut but triggered major damages
in secondary lymphoid organs, lungs and liver. Therefore, theImmunity 31, 197–208, August 21, 2009 ª2009 Elsevier Inc. 197
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guished from those that develop in mice constitutively or acutely
deprived of Foxp3+ regulatory T cells (Treg cells) (Kim et al., 2007;
Lahl et al., 2007). These differences are likely due to the fact that
the LatY136F pathology primarily results from a defect intrinsic to
conventional (Foxp3) CD4+ T cells. In support of that view, trans-
fer of wild-type Treg cells in neonatal LatY136F/Y136F mice was
unable to prevent the occurrence of the disorder (Wang et al.,
2008). Therefore, the LatY136F mutation constitutes the prototype
of a class of partial-loss-of-function mutations that paradoxically
associates the development of effector T cells responsible for
autoimmune and chronic inflammatory diseases to the presence
of TCR with crippled signaling ability (review in Liston et al., 2008).
The polyclonal CD4+ T cells that emerge in the periphery
of LatY136/Y136F mice have been selected on thymic MHC class
II (MHCII) molecules and express TCRs whose affinity for self
peptides bound to self MHCII molecules is shifted toward higher
values than in LAT-sufficient mice (Aguado et al., 2002). On that
basis, it has been proposed that, after triggering of such self-
reactive TCRs, the lack of Y136 of LAT creates an imbalance
among the positive and negative signals that are normally deliv-
ered by LAT molecules and that such imbalance results in exces-
sive positive signals that are responsible for the LatY136F lympho-
proliferative disorder (Sommers et al., 2005). Because of the
abnormal thymic T cell maturation that afflicts LatY136/Y136F
mice, it has been, however, difficult to establish the relative
importance of central versus peripheral defects in the etiology
of the LatY136F disorder and to identify the exact mechanisms
that result in the unique pathogenic behavior manifested by
postthymic LatY136F/Y136F CD4+ cells. To circumvent plausible
caveats resulting from constitutive expression of the LatY136F
mutation, we equipped postthymic CD4+ T cells that had
matured in a LAT-sufficient context with mutated (LATY136F)
molecules or rendered them defective in LAT molecules and
analyzed whether they give rise to disorders similar to the one
developing in LatY136F/Y136F mice.
RESULTS
Peripheral Expression of LATY136F Molecules
We derived gene-targeted mice with a loxP-flanked (floxed) wild-
type Lat allele (Figure S1 available online). To confer diphteria
toxin (DT) sensitivity to cells expressing such allele, a human
diphteria toxin receptor (DTR) cassette was also introduced
in its 30 untranslated region. This allele will be referred to as
Latfl-dtr. Consistent with the recessive nature of the LatY136F
mutation (Aguado et al., 2002; Sommers et al., 2002) and the
normal phenotype of mice expressing a single functional copy
of the Lat gene (Nunez-Cruz et al., 2003; Zhang et al., 1999b),
in Latfl-dtr/Y136F heterozygous mice, the wild-type LAT molecules
produced by the Latfl-dtr allele were sufficient to insure proper
thymic development and peripheral T cell functions (Figures
S2A–S2E and data not shown).
To deprive postthymic Latfl-dtr/Y136F CD4+ T cells from their
complement of wild-type LAT molecules and leave them equip-
ped with the sole LATY136F molecules, the Cre recombinase
was introduced via retroviral infection into peripheral CD4+
T cells isolated from Latfl-dtr/Y136F mice (Figure S3A). The small
percentage of CD4+ T cells that failed to be infected and thus198 Immunity 31, 197–208, August 21, 2009 ª2009 Elsevier Inc.kept a Latfl-dtr allele was subsequently killed through DT treat-
ment. This protocol insured over 6 days the production of a
pure population of cells—called LatD/Y136F CD4+ T cells—that
express only the LATY136F molecules and show no modification
in TCR Vb usage (Figures S2E and S3A–S3C). Therefore, the
Latfl-dtr/Y136F mice readily permit the conditional inactivation of
the Lat allele in peripheral CD4+ T cells that underwent a normal
process of thymic differentiation.
Latfl-dtr/Y136F CD4+ T Cells Have No Pathogenic Potential
The early-onset Th2 lymphoproliferative disorder that afflicts
LatY136F/Y136F mice starts in an environment that is replete in B
cells but contains abnormally low numbers of thymic CD4+
T cell emigrants (Aguado et al., 2002; Sommers et al., 2002).
BecauseCd3e-deficient (Cd3eD5/D5) mice lack T cells but contain
normal numbers of B cells (Malissen et al., 1995), they provide an
environment that mimics the one present in LatY136F/Y136F
neonates and were therefore used as recipients to determine
the properties of LatD/Y136F CD4+ T cells. Prior to assessing the
pathogenic potential of LatD/Y136F CD4+ T cells, we verified that
LatD/+ CD4+ cells that were derived from Cre-exposed and
DT-treated Latfl-dtr/+ CD4+ T cells and parental Latfl-dtr/Y136F
CD4+ T cells manifest no pathogenicity upon transfer into
Cd3eD5/D5 hosts because both have kept one functionalLatallele.
In line with previous studies with wild-type CD4+ T cells (Kieper
et al., 2005; Surh and Sprent, 2008; Wang et al., 2008), 8 weeks
after transfer of 3 3 106 Latfl-dtr/Y136F CD4+ T cells, 16 3 106
CD4+ T cells were recovered on average per Cd3eD5/D5 spleen
(Figures 1A and 2A) and similar yields were observed with LatD/+
CD4+ T cells (data not shown). At the time of their transfer and
because of their prior in vitro activation, Latfl-dtr/Y136F and LatD/+
CD4+ T cells showed an activated phenotype characterized by
slightly downmodulated amounts of CD3, increased expression
of CD44, and lower amounts of CD62L, a phenotype that they
retained when analyzed 6 to 8 weeks after adoptive transfer
(Figures 1C and 2C). As expected for the progeny of CD4+
T cells activated without attempting to polarize them into Th1 or
Th2 effectors, approximately 2% and 50% of the transferred
Latfl-dtr/Y136F and LatD/+ CD4+ T cells produced IL-4 and IL-2,
respectively, after in vitro stimulation with phorbol 12-myristate
13-acetate (PMA) and ionomycin (Figures 1B and 2B and data
not shown). Moreover, both types of transferred CD4+ T cells
had a limited impact on host B cells as supported by the lack of
CD95 molecules and the low amounts of MHCII molecules
observed on the B cell surface (Figures 1D and 2D) and by the
presence of serum Ig titers close to those found in wild-type
mice (Figure 2E). Taken together, these data indicate that,
provided they keep one functional Lat allele, CD4+ T cells that
were activated and expanded in vitro with anti-CD3 and anti-
CD28 acquired no pathogenic potential upon transfer into
Cd3eD5/D5 hosts. Akin to transferred wild-type CD4+ T cells,
they only partially restored the Cd3eD5/D5 peripheral T cell
compartment through homeostatic proliferation.
Pathogenic LatD/Y136F CD4+ T Cells
In contrast to the situation observed with both Latfl-dtr/Y136F and
LatD/+ CD4+ T cells, transfer of 3 3 106 LatD/Y136F CD4+ T cells
into Cd3eD5/D5 hosts led to splenomegaly and lymphadenop-
athy, and 8 weeks after transfer, the number of LatD/Y136F
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Figure 1. De Novo Expression of LATY136FMolecules in Postthymic CD4+ T Cells Promotes Their Conversion into Pathogenic Th2 Effectors
Splenocytes were isolated from wild-type mice, LatY136F/Y136F mice, and Cd3eD5/D5 mice reconstituted for 7 weeks with Latfl-dtr /Y136F or LatD/Y136F CD4+ cells.
(A) Expression of CD4 and B220 on total splenocytes. Numbers in outlined areas indicate percent CD4 and B220 cells.
(B) IL-2 and IL-4 production in single cells. CD4+ T cells were cultured for 4 hr in the presence (+) or absence () of PMA and ionomycin. Numbers in outlined areas
indicate percentage of cells.
(C) Expression of CD33, CD95, CD5, and CD44 on CD4+ splenocytes isolated from the specified mice. Dashed line indicates isotype control staining.
(D) Expression of MHC class II and CD95 on B220+ splenocytes from the specified mice. Dashed line indicates isotype control staining.
Data are representative of 5 independent experiments.CD4+ T cells reached approximately 124 3 106 per spleen
(Figures 1A and 2A). Although they conserved the
CD44hiCD62Llo phenotype acquired during in vitro activation,
the expanding LatD/Y136F CD4+ T cells started expressing lower
amounts of TCR and CD95 and higher amounts of CD5 as
compared to those found on transferred Latfl-dtr/Y136F CD4+
T cells (Figures 1C and 2C). Consistent with the acquisition of
such surface phenotype that resembles that of pathogenic
LatY136F/Y136F CD4+ T cells (Aguado et al., 2002; Sommers
et al., 2002), 32% ± 11% of the transferred LatD/Y136F CD4+
T cells produced robust amounts of IL-4 after stimulation with
PMA and ionomycin (Figures 1B and 2B). Such Th2-commited
LatD/Y136F CD4+ cells had a dramatic effect on resident B cells,
inducing their activation, as documented by the presence of up-
regulated levels of MHCII and CD95 molecules (Figures 1D and
2D). Whereas IgG1 and IgE were present at very low concentra-
tion in the serum of Cd3eD5/D5 hosts, 8 weeks after transfer of
LatD/Y136F CD4+ T cells, they increased 24-fold and 110-fold,
respectively (Figure 2E).Although the LatD/Y136F and LatD/+ CD4+ T cell inocula contain
the same frequency of Treg cells (data not shown), expression of
LATY136F molecules might have rendered LatD/Y136F Treg cells
nonfunctional. The small numbers of Treg cells present at the
end of the in vitro conditioning step precluded, however, the
direct analysis of their functional capacity. Therefore, to deter-
mine whether LatD/Y136F CD4+ T cells behave differently from
wild-type CD4+ T cells relieved from Treg cell-mediated
suppression, we performed parallel transfer experiments in-
volving wild-type CD4+ T cells that went through the same
in vitro activation protocol as LatD/Y136F CD4+ T cells and that
were depleted of Treg cells prior to their transfer into Cd3eD5/D5
mice. Upon transfer, those cells showed a much more limited
proliferative capacity than LatD/Y136F CD4+ cells and acquired
neither the TCRlo, CD5hi, CD95lo phenotype nor the exacerbated
Th2 polarization that characterize CD4+ T cells expressing
LATY136F molecules in a constitutive or conditional manner
(Figure S4). Moreover as previously described (Martin et al.,
2004), Cd3eD5/D5 mice injected with wild-type activated CD4+Immunity 31, 197–208, August 21, 2009 ª2009 Elsevier Inc. 199
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Etiology of LatY136F Lymphoproliferative DisorderT cells deprived of Treg cells showed a rapid loss of weight and
developed intestinal bowel disease (data not shown). Therefore,
equipping postthymic CD4+ T cells with LATY136F molecules
suffices to convert them into pathogenic cells that trigger a Th2
lymphoproliferative disorder resembling that of LatY136F/Y136F
mice but differing from the immunopathology induced by CD4+
T cells relieved of Treg cell control. Such marked difference likely
stems from the fact that conventional LatD/Y136F CD4+ T cells are
equipped with a crippled TCR signaling cassette.
Conversion Requires MHCII and CD28 Molecules
To assess whether LatD/Y136F CD4+ T cells required MHCII mole-
cules and by inference TCR signals to acquire a pathogenic
potential, we transferred them into Cd3eD5/D5 recipients
deprived of MHCII molecules (Cd3eD5/D5 MHCII-deficient mice;
Martin et al., 2006). 50 days after transfer, small numbers of
LatD/Y136F CD4+ T cells were recovered and those cells had
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Figure 2. Phenotype and Effector Function
of Transferred LatD/Y136F CD4+ T Cells
Analysis of CD4+ cells and B220+ B cells found in
the spleen of Cd3eD5/D5 recipients 7–8 weeks after
reconstitution with Latfl-dtr /Y136F (non floxed: NF) or
LatD/Y136F (floxed: F) CD4+ T cells.
(A) Total and CD4+ T cell content.
(B) Percentage of IL-4-producing CD4+ T cells after
a 4 hr stimulation with PMA and ionomycin.
(C) Geometric mean of TCR, CD95, and CD5
surface expression on Latfl-dtr /Y136F and LatD/Y136F
CD4+ T cells normalized to that of wild-type CD4+
T cells.
(D) Geometric mean of MHC class II expression on
Latfl-dtr/Y136F and LatD/Y136F B220+ B cells normal-
ized to that of wild-type B220+ B cells (left) and
frequency of CD95+ B cells among B220+ cells
(right).
(E) Concentrations of IgG1 and IgE antibodies in
serum samples.
The values corresponding to each individual
mouse are shown and the mean (horizontal bar)
and standard deviation are indicated for each
panel. Data are representative of 5 independent
experiments performed on 7 and 13 Cd3eD5/D5
recipients reconstituted with Latfl-dtr/Y136F and
LatD/Y136F CD4+ T cells, respectively.
maintained a surface phenotype identical
to control Latfl-dtr/Y136F CD4+ T cells
(Figures 3A and 3B). Therefore, MHCII
molecules are necessary for the conver-
sion of LatD/Y136F CD4+ T cells into patho-
genic cells. We analyzed next whether the
CD28 costimulatory receptor was also
needed for the pathogenic conversion of
LatD/Y136F CD4+ T cells. We first generated
Cd28/ Latfl-dtr/Y136F mice and verified
that they had no impaired T cell develop-
ment and contained normal numbers of
peripheral T cells (data not shown). We
then prepared Cd28/ LatD/Y136F CD4+
T cells, as described for LatD/Y136F CD4+
cells, and transferred them into Cd3eD5/D5 recipients. 50 days
after transfer, the infused Cd28/ LatD/Y136F CD4+ T cells had
kept a surface phenotype identical to Latfl-dtr/Y136F CD4+ control
T cells and triggered no disorder (Figure 3A and data not shown).
Therefore, upon transfer into Cd3eD5/D5 recipients, the conver-
sion of LatD/Y136F CD4+ T cells into pathogenic Th2 effectors
does not occur ‘‘spontaneously’’ but instead requires TCR
signals that, akin to primary antigenic responses, also necessi-
tate the contribution of the CD28 costimulator.
Time Course of Pathogenic Conversion
To follow the time course of the conversion into pathogenic Th2
effectors and determine whether the whole cohort of transferred
cells undergoes conversion, LatD/Y136F CD4+ T cells were labeled
with CFSE and transferred into Cd3eD5/D5 mice that express or
lack MHCII molecules. Control experiments involving the trans-
fer of Latfl-dtr/Y136F CD4+ T cells showed that these cells were200 Immunity 31, 197–208, August 21, 2009 ª2009 Elsevier Inc.
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Etiology of LatY136F Lymphoproliferative Disorderthe object of two coincident and independent phenomena iden-
tical to those that have been previously described for wild-type
CD4+ T cells transferred into constitutively immunodeficient
mice, including Cd3eD5/D5 mice (Kieper et al., 2005; Martin
et al., 2006; Min et al., 2005; Wang et al., 2008). The majority of
Latfl-dtr/Y136F CD4+ T cells proliferated very slowly, accounting
for the CFSE+ peaks observed at day 6 after transfer (Figure 4A).
In contrast, a fraction of them proliferated extensively, yielding
a prominent peak of CFSE cells 6 days after transfer. The
generation of such CFSE cells was strictly dependent on inter-
actions with MHCII molecules (Figure 4A). It has been suggested
that antigenic peptides derived from enteric bacteria present in
constitutively immunodeficient hosts are responsible for this
TCR-driven, explosive proliferation (Kieper et al., 2005; Martin
et al., 2006; Min et al., 2005). Importantly, as previously noted
(Surh and Sprent, 2008), such extensive, antigen-driven prolifer-
ation subsided rapidly and triggered no detectable immune
pathology (Figure 2).
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Figure 3. TCR- and CD28-Mediated Signals Are Required for the
Conversion of LatD/Y136F CD4+ T Cells into Pathogenic Cells
(A) Number of CD4+ T cells present in the spleen ofCd3eD5/D5 hosts that express
(Cd3eD5/D5) or are deprived of MHCII molecules (MHCII-deficient Cd3eD5/D5)
and were reconstituted for 50 days with LatD/Y136F or with Cd28/
LatD/Y136F CD4+ T cells. Data are representative of 3 independent experiments
performed on 4Cd3eD5/D5 recipients and 8Cd3eD5/D5MHCII-deficient recipients.
(B) Expression of TCRb, CD95, and CD5 on CD4+ splenocytes from wild-type,
LatY136F/Y136F, and Cd3eD5/D5 hosts that express (Cd3eD5/D5) or are deprived
of MHCII molecules (MHCII-deficient Cd3eD5/D5) and were reconstituted for
50 days with Latfl-dtr /Y136F or LatD/Y136F CD4+ T cells. Also shown is the pheno-
type of LatD/Y136F CD4+ T cells transferred into Cd3eD5/D5 recipients. Dashed
lines indicate isotype control staining.Markedly distinct CFSE profiles were observed in the case of
LatD/Y136F CD4+ T cells (Figure 4A). Nine days after transfer, most
of the LatD/Y136F CD4+ T cells had completed only a few divisions.
However, a fraction of the CFSE+ cells present at day 9 progres-
sively converted into CFSE cells over the following days and in
a manner that was strictly dependent on the expression of MHCII
molecules by the host (Figure 4A). At day 13, a time point with an
even representation of the CFSE+ and CFSE fractions, CFSE
cells were found to differ from CFSE+ cells in that they already
expressed downmodulated TCR and higher levels of CD5
(Figure 4B), two hallmarks of pathogenic LatY136F/Y136F CD4+
T cells (Aguado et al., 2002; Sommers et al., 2002). The first
LatD/Y136F CD4+ T cells capable of secreting IL-4 upon in vitro
stimulation were detected approximately 15 days after transfer
(data not shown). Importantly, the proliferation of the CFSE
LatD/Y136F CD4+ T cells continued unabated, yielding potent
Th2 effectors and leading over the following weeks to patholog-
ical conditions similar to those observed in LatY136F/Y136F mice
(Figures 1 and 2). Analysis of the Vb repertoire expressed by
the progeny of the expanding LatD/Y136F CD4+ T cells revealed
a polyclonal Vb repertoire, suggesting that such TCR-driven
proliferation involved a substantial fraction of the transferred
LatD/Y136F CD4+ T cells (data not shown). Therefore, upon inter-
action with MHCII molecules, Latfl-dtr/Y136F CD4+ T cells mani-
fested the extensive but transient proliferation that characterizes
normal antigenic responses whereas LatD/Y136F CD4+ T cells
proliferated at a slower pace that did not subside over time.
Conversion in LatY136F/Y136F Newborn Mice
To determine whether a similar sequence of events also
occurred in LatY136F/Y136F mice, we monitored the first signs of
Th2 commitment among the minute numbers of CD4+ T cells
that are present in LatY136F/Y136F mice 3–18 days after birth.
For that purpose, LatY136F/Y136F mice were first crossed with
IL-4 reporter mice (4get) in which a green fluorescent protein
(GFP) has been targeted to the 30 untranslated region of the en-
dogeneous Il4 gene (Mohrs et al., 2001). CD4+ T cells were
detectable in the spleen of 4get mice 3 days after birth and their
numbers increased steadily during the subsequent days
(Figure S5). Consistent with the impeded thymic development
present in LatY136F/Y136F mice, it was only 9 days after birth that
the first CD4+ T cells were detected in the periphery of
LatY136F/Y136F 4get mice. However, these cells subsequently
embarked in a dramatic expansion, catching up with wild-type
numbers approximately 3 weeks after birth (Figure S5). CD4+
T cells from 4get mice remained GFP at all the time points
analyzed whereas Th2-committed (GFP+) CD4+ T cells were
already detectable in 9-day-old LatY136F/Y136F 4get spleens and
increased in percentage over the following days (Figure S5).
Analysis of 15-day-old LatY136F/Y136F 4get spleens revealed
that the GFP CD4+ T cells were uniformly CD3+ whereas the
Th2-commited (GFP+) CD4+ T cells expressed low amounts of
CD3 at their surface, a feature suggestive of recent TCR engage-
ment. Therefore, the presence in the periphery of 15-day-old
LatY136F/Y136F mice of two CD4+ T cell populations expressing
inversely correlated amounts of Il4 transcripts and of TCR is
consistent with the results observed with transferred LatD/Y136F
CD4+ T cells (Figures 3 and 4). These data suggest that the first
CD4+ T cells seeding the periphery of LatY136F/Y136F mice alsoImmunity 31, 197–208, August 21, 2009 ª2009 Elsevier Inc. 201
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and conversion into pathogenic Th2 effector cells.
Peripheral Ablation of LAT
To assess whether the conversion into pathogenic Th2 effector
requires residual signals from LATY136F molecules, we derived
mice coexpressing a Latfl-dtr and a null allele (Lat) of the Lat gene.
After verifying that Latfl-dtr/ mice had no impairment in T cell devel-
opment and T cell function (Figure S2), LatD/ CD4+ T cells were
prepared as described for LatD/Y136F CD4+ T cells and shown to
be deprived of the Latfl-dtr allele and of LAT molecules at the time
of their transfer (Figures S3C and S3D).LatD/CD4+ T cells triggered
a Th2 pathology that fully mimicked the one observed after transfer
of LatD/Y136F CD4+ T cells (Figure 5; Figure S6). In particular, LatD/
CD4+ T cells produced large amounts of IL-4 and were capable
of triggering B cell activation and IgG1 and IgE hypergammaglobu-
linemia (Figure 5C; Figure S6). As previously documented for
LatY136F/Y136F CD4+ T cells, the pathogenic LatD/ CD4+ T cells
expressed lower levels of TCR and of CD95 and increased amounts
of CD5 (Figures 5A and 5B; Figure S6).
We sought to confirm that the TCR does not need to cooperate
with LATY136F molecules to trigger Th2 lymphoproliferative
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Figure 4. Time-Course Analysis of the
Conversion of LatD/Y136F CD4+ T Cells into
Pathogenic Cells
Latfl-dtr/Y136F and LatD/Y136F CD4+ T cells were
CFSE labeled and separately transferred into
Cd3eD5/D5 hosts that express (Cd3eD5/D5) or are
deprived of MHCII molecules (MHCII-deficient
Cd3eD5/D5).
(A) CFSE profiles of transferred CD4+ T cells were
analyzed 6, 9, and 13 days after transfer. The
percentage of CFSE+ and CFSE cells observed
at day 13 is indicated. Data are representative of
2 to 3 mice per time point and per genotype.
(B) Amounts of TCRb and CD5 observed 13 days
after transfer on the specified CFSE+ and CFSE
cells (see key). Also shown is the phenotype of
LatY136F/Y136F CD4+ T cells.
disorders similar to the one originally
described in LatY136F/Y136F mice by using
an approach that relied neither on in vitro
activation nor on adoptive transfer of
Cre-exposed T cells. For that purpose,
we used mice with thymus-specific
expression of a gain-of-function allele of
Lck (LckY505F) (Abraham et al., 1991). In
Lat/ LckY505F thymi, the pulse of Lck
activity provided by the LckY505F trans-
gene substituted for the signaling-incom-
petent pre-TCR and TCR and allowed
the emergence of LAT-deficient CD4+
T cells in the periphery. The surface
phenotype of the CD4+ T cells present in
the periphery of Lat/ LckY505F mice
was found identical to that of CD4+
T cells expressing LATY136F molecules
and 60% of those cells produced IL-4
after stimulation with PMA and ionomycin (Figure 6 and data
not shown). Moreover, analysis of T and B cellularities and of
serum IgG1 and IgE concentrations concurred to demonstrate
that the LAT-deficient CD4+ T cells that expanded in the
periphery of Lat/ LckY505F mice triggered a Th2 lymphoprolifer-
ative disorder similar to the one observed in LatY136F/Y136F mice
or in Cd3eD5/D5 hosts reconstituted with LatD/ or LatD/Y136F
CD4+ cells (Figure 6). In contrast, the CD4+ T cells found in the
periphery of LAT-sufficient, LckY505F mice were present in
normal numbers and showed no sign of pathogenicity (Figure 6).
Therefore, when CD4+ T cells are acutely (Figure 5; Figure S6) or
constitutively (Figure 6) deprived of LAT molecules, they embark
into a Th2 lymphoproliferative disorder that largely recapitulates
the disorder originally documented in mice with germline expres-
sion of the LatY136F mutation. Together, these data suggest that
the TCR signals that are responsible for the initiation of the
LatY136F pathology are conveyed independently of the tyrosine
residues left in LATY136F molecules.
TCR Signaling in LatY136F/Y136F CD4+ T Cells
In the course of expansion, LatY136F/Y136F CD4+ T cells under-
went a conversion into effector cells that expressed on their202 Immunity 31, 197–208, August 21, 2009 ª2009 Elsevier Inc.
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present on naive or effector CD4+ T cells (Aguado et al., 2002;
Sommers et al., 2002). Such reduction in TCR expression corre-
lated with a global decrease in TCR-induced protein phosphor-
ylation (Figure S7A; Sommers et al., 2002). For instance, tyrosine
phosphorylation of phospholipase PLCg1 and serine phosphor-
ylation of the serine-threonine protein kinase Akt were totally
abrogated in expanding LatY136F/Y136F CD4+ T cells (Figures
S7B and S7C). Consistent with a study based on LAT-deficient
double-positive thymocytes (Shen et al., 2009) but at variance
with another report (Sommers et al., 2002), we found that TCR-
induced ERK phosphorylation was defective in LatY136F/Y136F
CD4+ T cells, regardless of the time point at which the analysis
was performed (Figure S7C). In contrast to ZAP-70, Lck was still
capable of being tyrosine phosphorylated after TCR engage-
ment (Figure S7B). The lack of ZAP-70 phosphorylation, for
which the reason remains to be determined, might explain
together with the reduced amounts of surface TCR that expand-
ing LatY136F/Y136F CD4+ T cells are refractory to TCR signals. The
aforementioned conclusions primarily derive from biochemical
analyses performed on CD4+ T cells isolated from LatY136F/Y136F
mice where the lymphoproliferative disorder was already largely
established. By distantly reflecting the TCR signaling capability
CD4+ B220+
CD3ε
CD95
CD5
CD95
CD44
MHCII
CD4
C
D
3
L
a
t
 
fl-
dt
r/−
L
a
t
 
Δ/
−
C
d
3
e
Δ5
/Δ
5
C
d
3
e
Δ5
/Δ
5
C
d
3
e
Δ5
/Δ
5
L
a
t
 
Y
13
6F
/Y
13
6F
L
a
t
 
Δ/
+
A B C
Figure 5. Acute Removal of LAT Molecules
in Mature CD4+ T Cells Suffices to Promote
Their Conversion into Pathogenic Th2 Cells
Flow cytometry of splenocytes from LatY136F/Y136F
mice and from Cd3eD5/D5 recipients reconstituted for
7 weeks with Latfl-dtr/, LatD/, or LatD/+ CD4+ T cells.
(A) CD3 and CD4 expression on total splenocytes.
Numbers in outlined areas indicate percentage of
cells.
(B) Expression of CD33, CD95, CD5, and CD44 on
CD4+ splenocytes from the specified mice (see
key below histograms shown in C).
(C) Expression of MHCII and CD95 on B220+ sple-
nocytes from the specified mice (see key).
Dashed lines indicate isotype control staining.
Data are representative of 3 independent experi-
ments performed on 9 and 14 Cd3eD5/D5 recipi-
ents reconstituted with control and LatD/ CD4+
T cells, respectively. Controls include Cd3eD5/D5
recipients reconstituted with LatD/+ (n = 4) and
Latfl-dtr/ (n = 5) CD4+ T cells.
of CD4+ T cells recently made defective
in LAT molecules, they likely provide
limited hints on the mechanisms that are
responsible for the initiation of the
LatY136F lymphoproliferative disorder.
Therefore, we refocused our biochemical
analysis on postthymic CD4+ T cells
made freshly defective in LAT molecules.
LAT-Independent TCR Signals
Cause the Pathological Conversion
CD4+ T cells purified from Latfl-dtr/fl-dtr and
Latfl-dtr/+ mice were successively ex-
posed to the Cre recombinase and to
DT and then kept in culture for three additional days in the pres-
ence of IL-2 to allow the complete decay of the pool of LAT mole-
cules. The resulting LatD/D and LatD/+ CD4+ T cells were either left
untreated or were stimulated with anti-CD3 plus anti-CD4 for
2 min and whole-cell lysates were analyzed for their pattern of
tyrosine phosphorylated proteins (Figure 7A). Importantly, no
band of the size expected for phosphorylated LAT species was
present in LatD/D CD4+ T cells, a result confirmed by using an
antibody specific for LAT. Therefore, the expression of LAT
molecules has decayed to undetectable amounts 7 days after
Cre exposure of Latfl-dtr/fl-dtr CD4+ T cells, permitting us to deter-
mine the scope of TCR signaling events that occurred in non-
transformed CD4+ T cells in the absence of LAT molecule. More-
over, because LatD/D and LatD/+ CD4+ T cells express identical
amounts of cell-surface TCR (data not shown), they allowed
unambiguous conclusions to be drawn about the signaling
potency of their TCR. Inducible tyrosine phosphorylation of
CD3z, Lck, and ZAP-70, three key components of the TCR trig-
gering module that lies upstream of LAT (Acuto et al., 2008;
Malissen, 2003), was unaffected in LatD/D CD4+ cells
(Figure 7B and data not shown). In addition, tyrosine phosphor-
ylation of the E3 ubiquitin ligase c-Cbl that binds to phosphory-
lated isoforms of ZAP-70 and LAT was unimpaired in LatD/DImmunity 31, 197–208, August 21, 2009 ª2009 Elsevier Inc. 203
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Etiology of LatY136F Lymphoproliferative DisorderCD4+ T cells (Figure 7B). Conversely, PLCg1 phosphorylation
that depends both on the presence and on the phosphorylation
of LAT was totally impaired in LatD/D CD4+ T cells (Figure 7B).
Consistent with the lack of inducible PLCg1 phosphorylation,
LatD/D CD4+ T cells showed almost no intracellular calcium mobi-
lization and no ERK 1 and 2 activation after TCR engagement
(Figures 7B and 7C). TCR crosslinking also failed to induce
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(A) Expression of CD4 and CD8 on total splenocytes from Lat+/+ LckY505F and
Lat/ LckY505F mice. Numbers in outlined areas indicate percentage of cells.
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control staining.
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The mean (horizontal bar) and standard deviation are indicated for each panel.
Data are representative of 6 independent experiments performed on 9-week-
old mice.204 Immunity 31, 197–208, August 21, 2009 ª2009 Elsevier Inc.IFN-g production (Figure 7D), a process that requires the activa-
tion of NF-AT transcription factors and that is thus dependent on
calcium mobilization. Therefore, the proximal TCR triggering
module is fully functional in LatD/D CD4+ T cells but uncoupled
from several signaling pathways thought to be mandatory for
CD4+ T cell activation and differentiation into effector cells. Para-
doxically, upon transfer into Cd3eD5/D5 hosts, a substantial frac-
tion of LatD/D CD4+ T cells embarked into a TCR-driven activation
process that led to the emergence of continuously proliferating,
full-fledged Th2 effectors that resemble those originally ob-
served in mice expressing a constitutive LatY136F allele.
A solution to this paradox can be sought in the comparison of
the pattern of phosphorylated proteins that are present in LatD/D
and LatD/+ CD4+ T cells after stimulation through the TCR
(Figure 7A). If a 110 kDa phosphospecies that is absent in
TCR-stimulated LatD/D CD4+ T cells is excluded, most of the
phosphorylated species present in LatD/+ CD4+ T cells can
also be found in LatD/D CD4+ T cells (Figure 7A). For instance,
TCR-induced tyrosine phosphorylation of the adaptor protein
SLP-76 remained unaffected in the absence of LAT (Figure 7B),
suggesting that SLP-76 has another entry point in the TCR
signaling cassette in addition to LAT. Moreover, the TCR ex-
pressed at the surface of LatD/D CD4+ T cells was capable of
turning on the PI3K lipid kinase as documented by the presence
of inducibly serine phosphorylated Akt species (Figure 7B;
Figure S8). Consistent with the view that the function of the
PI3K lipid kinase is largely unaffected in LatD/D CD4+ T cells,
glycogen synthase kinase-3b, a substrate for Akt that is phos-
phorylated upon TCR activation in a PI3K-dependent manner,
showed the same extent of TCR-induced serine phosphorylation
in both LatD/D and LatD/+ CD4+ T cells (Figure S8). Lck and ZAP-
70, the two protein tyrosine kinases that are most proximal to the
TCR, were thus still capable of phosphorylating a wealth of
substrates in the absence of LAT (Figure 7) or in the presence
of LATY136F molecules (data not shown). Therefore, the fact
that such LAT-independent TCR-driven signals result in an exac-
erbated cascade of T cell activation and differentiation strongly
suggests that molecules the function of which is controlled by
LAT exert a repressive function on the segment of the TCR
signaling cassette that lies upstream of LAT or that functions
independently of LAT.
DISCUSSION
To prevent expression of TCRs whose affinity for self is shifted
toward higher values than in wild-type mice, a developmental
alteration known to be associated with germline expression of
the LatY136F mutation (Aguado et al., 2002), we equipped post-
thymic CD4+ T cells only with LATY136F molecules or made
them defective in LAT molecules. The TCRs expressed by the re-
sulting LatD/Y136F and LatD/ CD4+ T cells were thus calibrated in
the thymus in the context of signaling-proficient LAT molecules
and subsequently forced to function with LATY136F molecules
or in the absence of LAT molecules, respectively. Because LAT
is required for TCR-mediated activation of the Jurkat T cell line
(Finco et al., 1998; Zhang et al., 1999a), the elimination of LAT
molecules or their substitution with LATY136F molecules at
a postthymic stage was expected to blunt TCR signals and to
result in the generation of inert CD4+ T cells. However, upon
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Figure 7. TCR Signaling Capability of CD4+ T Cells Freshly Made Defective in LAT
CD4+ T cells from Latfl-dtr/fl-dtr and Latfl-dtr/+ mice were activated and exposed to the Cre recombinase and to DT for 2 days. The resulting LatD/D and LatD/+ CD4+
T cells were kept in culture for 3 days in the presence of IL-2 prior to analysis.
(A and B) Cells were left untreated () or stimulated (+) with anti-CD3 and anti-CD4 for 2 min at 37C prior to isolation of whole-cell lysates. In (A), equivalent
amounts of lysates were separated by SDS-PAGE and analyzed by immunoblot with antibody specific for phosphotyrosine (pY) or LAT (LAT). Also indicated
is the position of LAT and of a 110 kDa species the phosphorylation of which depends on the presence of LAT. In (B), TCR-inducible tyrosine phosphorylation
of specific proteins was assessed by immunoblotting with phospho-tyrosine-specific antibodies directed against Src pY416, ZAP-70 pY319, SLP-76 pY128,
c-Cbl pY774, PLC-g pY783, Akt pS473, and ERK1 and 2 pTY202/204 and with antibodies specific for the corresponding proteins.
(C) Changes in intracellular calcium in LatD/D and Latfl-dtr/+ CD4+ T cells stimulated with biotinylated anti-CD3 and avidin. The arrow corresponds to the time of
avidin addition. Both LatD/D and Latfl-dtr/+ CD4+ T cells exhibited robust calcium fluxes when stimulated with ionomycin (data not shown).
(D) LatD/D and Latfl-dtr/+ CD4+ T cells were stimulated with graded concentration of anti-CD3 in the presence of a fixed concentration (0.5 mg/ml) of CD28 antibody.
The content of IFN-g present in the culture supernatant was measured after 48 hr of culture. Also shown is the amount of IFN-g obtained after stimulation with
PMA and ionomycin.
Data are representative of 3 independent experiments.transfer intoCd3eD5/D5 host, the fraction of transferred LatD/Y136F
and LatD/ CD4+ T cells engaging in TCR-driven responses
became potent Th2 effector cells that rapidly outnumbered the
remaining cells undergoing TCR-independent homeostatic
proliferation. Considering that it is difficult to envisage how
decreasing or ablating LAT signaling activity at a postthymic
stage can increase TCR affinity for syngeneic MHC molecules
(Lin et al., 1997), it is likely that the TCR expressed on the trans-
ferred LatD/Y136F and LatD/ CD4+ T cells responded to MHCII-
bound peptides derived from the commensal flora present in
the Cd3eD5/D5 hosts (Surh and Sprent, 2008).
We propose to call ‘‘LAT signaling pathology’’ (LSP) the lym-
phoproliferative syndromes with excessive production of Th2
cytokines that are characteristic of the presence of defective
LAT signalosome. Such lymphoproliferative disorders do not
necessarily require a prior defective central tolerance in that
they also unfold when appropriately calibrated postthymic
LatD/Y136F and LatD/ CD4+ T cells embark in conventional anti-
genic responses. On that basis and as discussed below, wewould like to suggest that LSP primarily results from the fact
that, once assembled, LAT signalosomes not only deliver posi-
tive signals but also attenuate the activity of components of
the TCR signaling cassette that lie upstream of them or function
independently of them. Accordingly, in the absence of LAT or
in the presence of crippled LAT molecules, TCR engagement
triggers a signaling cascade that leads to the differentiation of
full-fledged effector T cells, the proliferation and the function
of which escape from the control of the TCR-LAT axis. Impor-
tantly, this corrupted sequence of T cell activation unfolds when-
ever the TCR is triggered and regardless of its autoreactive
(LatY136F/Y136F CD4+ T cells) or antigen-reactive (LatD/Y136F and
LatD/ CD4+ T cells) nature. Comparison of the kinetics of
MHCII-dependent proliferation manifested by transferred
Latfl-dtr/Y136F and LatD/Y136F CD4+ T cells demonstrated that
Latfl-dtr/Y136F CD4+ T cells proliferated in a fast manner whereas
the proliferation of LatD/Y136F CD4+ T cells showed longer cell
cycle times and a markedly protracted onset. Therefore, the
function of LAT is dual in that, as originally hypothesized, itImmunity 31, 197–208, August 21, 2009 ª2009 Elsevier Inc. 205
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TCR-driven T cell expansion.
Our results provide a unifying model on the etiology of LSP that
accounts for the disorders observed in mice expressing both
partial-loss-of-function (LatY136F) and null alleles of Lat. It is
different from a previous model that suggested that LATY136F
molecules are unique in that they deliver excessive positive
signals that were causative of the LatY136F disorder (Sommers
et al., 2002) and it is further supported by the following observa-
tions. First, although LAT molecules having tyrosine to phenylala-
nine substitution in the three carboxy-terminal tyrosine residues
(LATY7/8/9F molecules) possess residual signaling capacities
that are totally distinct from LATY136F molecules (Zhang et al.,
2000), they still permit the development of a lymphoproliferative
disorder involving Th2-like gd cells (Nunez-Cruz et al., 2003).
Second, although the CD4+ T cells found in the periphery of
Lat/ LckY505F mice are constitutively deprived of LAT, they
manifest a pathogenic potential identical to that of LatY136F/Y136F
T CD4+ cells. Therefore, the fact that similar lymphoproliferative
disorders with excessive production of Th2 cytokines can be trig-
gered by partial-loss-of-function (LatY136F, LatY7/8/9F) or null
alleles of Lat strongly suggests that it is not the residual tyrosine
residues left in both LATY136F and LATY7/8/9F molecules that
trigger such syndromes.
How can mutations that destroy a major signaling hub that
bridges the T cell-specific and the ubiquitous components of
the TCR signaling pathway paradoxically result in signals that
drive the expansion and differentiation of full-fledged Th2 effec-
tors capable of giving rise to agressive lymphoproliferative disor-
ders? By using postthymic CD4+ T cells freshly made defective in
LAT molecules, we observed that LAT-dependent, TCR-driven
events, such as tyrosine phosphorylation of PLCg1, calcium
mobilization, and cytokine production, were totally abrogated.
Therefore, TCR engagement converted LatD/ CD4+ T cells
into pathogenic Th2 effectors without detectable TCR-induced
calcium influx. Particularly relevant to this last observation,
T cell-specific ablation of the sensors of stored calcium STIM1
and STIM2 also resulted in CD4+ T cells that underwent a slow
proliferation after TCR stimulation and gave rise to a Th2 lympho-
proliferative disorder (Oh-Hora et al., 2008). Consistent with
observations made with Jurkat T cells deprived of LAT molecules
(Finco et al., 1998; Houtman et al., 2005; Zhang et al., 1999a),
Lck and ZAP-70 were fully functional in CD4+ T cells recently
deprived of LAT molecules. In the absence of LAT and upon
TCR engagement, Lck and ZAP-70 induced a spectrum of
protein tyrosine phosphorylation that largely overlapped the
one observed in the presence of LAT. This constitutes an unex-
pected observation considering that LAT is thought to bring a
multitude of protein substrates in the vicinity of Lck and ZAP-
70. A common cause for the recurrent and aggressive immune
disorders that result from the presence of defective LAT mole-
cules can thus be sought in the lack of a negative regulatory
loop that normally keeps in check the activity of the proximal
TCR-triggering module and of the LAT-independent TCR
signaling branches that we documented in CD4+ T cells recently
deprived of LAT molecules. Because of the cooperative interac-
tions that control assembly of LAT signalosomes (Bunnell et al.,
2006), the activation of such negative regulatory loop might
require the prior assembly of full LAT signalosomes and thereby206 Immunity 31, 197–208, August 21, 2009 ª2009 Elsevier Inc.account for the similar phenotypes observed in mice expressing
partial-loss-of-function or null alleles of Lat. Accordingly, when
TCR signaling proceeds in the absence of LAT, a coinhibitor
such as CTLA-4 might not be activated or a negative regulator
might not be recruited, leaving the activity of the proximal TCR
triggering module unchecked. Importantly, LAT has already
been suspected to attenuate T cell activation. For instance,
phosphorylated LAT molecules can recruit through GRB2 the
tyrosine phosphatase SHP2, which in turn downregulates
T cell activation (Yamasaki et al., 2003). The adaptor proteins
downstream of kinases (DOK) 1 and 2 also form a multimolecular
complex with phosphorylated LAT molecules that includes the
lipid phosphatase SHIP-1 and the suppressor of RAS activation
RASGAP and thereby negatively regulate early TCR signals
(Dong et al., 2006; Yasuda et al., 2007). Congruent with our
views, the TCR signaling cassette has been previously hypothe-
sized to be composed of a LAT-dependent and of a LAT-inde-
pendent branch, the latter being normally subjected to the nega-
tive control of the former (Chiang et al., 2004).
It is important to stress that the unique position occupied by
the LAT adaptor within the TCR signaling cascade probably
accounts for the recurrent and devastating phenotypes that
result from the crippling of its signaling ability: in the absence
of intact LAT signalosomes, the function of the proximal TCR-
triggering module and the activation of the LAT-independent
signaling branches are fully preserved but fails to be desensi-
tized. In support of that view, it should be stressed that no
pathology ensued when postthymic CD4+ T cells were acutely
depleted of Lck and Fyn, the two kinases through which the
proximal TCR triggering module is ignited, and transferred into
immunodeficient hosts (Seddon et al., 2003). It remains to be
determined which effector molecules are subjected to the LAT-
operated negative-feedback loop. In the course of activation,
LatD/Y136F and LatD/ CD4+ T cells underwent a conversion into
a state where they express dramatically reduced amounts of
TCR at their surface and became refractory to TCR engagement.
Dramatically reduced amounts of TCR are also present at the
surface of gd and CD8+ T cells that express mutated forms of
LAT and give rise to lymphoproliferative disorders (Archambaud
et al., 2009; Nunez-Cruz et al., 2003). Because the TCRlo pheno-
type of LatY136F/Y136F CD4+ T cells can not be reversed by pre-
venting TCR-MHCII interactions (Wang et al., 2008), such strin-
gent TCR dowregulation likely results from intrinsic constitutive
signals triggered by the presence of defective LAT signalo-
somes. Considering that downregulated expression of surface
TCR have been associated with the expression a constitutively
active form of Lck (D’Oro et al., 1997) and that two recent models
postulated that LAT plays a role in repressing Lck activity either
directly (Kabouridis, 2003) or through ERK, a distal effector of the
LAT-signaling axis (Altan-Bonnet and Germain, 2005), it is thus
plausible that Lck constitutes one of the targets of the LAT-oper-
ated negative-feedback loop.
In conclusion, our data demonstrate that the development of
lymphoproliferative disorders with excessive production of Th2
cytokines that are proper to the presence of a defective LAT sig-
nalosome require neither faulty thymic T cell maturation nor
excessive positive signals propagated by LATY136F molecules.
Such disorders likely result from the lack of a LAT-operated
negative regulatory loop intrinsic to conventional CD4+ T cells
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anisms mediated by Treg cells. In its absence, physiologic,
antigen-specific CD4+ T cell responses evolve into chronic
proinflammatory responses that perpetuate themselves in a
TCR-independent manner and induce the production of massive
amounts of antibodies and autoantibodies in an MHCII-indepen-
dent, ‘‘quasimitogenic’’ mode (Genton et al., 2006; Wang et al.,
2008). It has been reported that the T cells that reside in the syno-
vium of the inflamed joints of patients with rheumatoid arthritis
displace LAT from the cytoplamsic membrane because of redox
balance alterations (Gringhuis et al., 2000, 2002). Akin to the situ-
ation observed in postthymic CD4+ T cells made defective in LAT
molecules, membrane displacement of LAT under conditions
of chronic oxidative stress might thus convert such T cells into
LatD/ -like CD4+ T cells capable of secreting excessive amounts
of cytokines and of helping B cells in a quasimitogenic mode. The
present work thus raises the possibility that some pathological
conditions collectively called ‘‘autoimmune’’ on the basis of the
presence of autoantibodies might not result from the presence
of self-reactive T cells but from defect in cell-intrinsic mecha-
nisms that normally keep in check physiologic CD4+ T cell
responses and prevent their evolution into antigen-independent
chronic responses.
EXPERIMENTAL PROCEDURES
Mice
The generation of Latfl-dtr mice (B6;129-Lattm6Mal) is described in the Supple-
mental Data. The 129/SV-derived Latfl-dtr mice have been backcrossed onto
C57BL/6 mice for 5 generations. LatY136F (Aguado et al., 2002), Lat/
(Nunez-Cruz et al., 2003), Cd28/ (Shahinian et al., 1993), Cd3eD5/D5 (Malis-
sen et al., 1995), and 4get (Mohrs et al., 2001) mice have been described.
Cd3eD5/D5 mice deficient in MHCII (Cd3eD5/D5MHCII-deficient) were derived
by using MHCII-deficient (Madsen et al., 1999) mice. LckY505F Lat/ mice
were derived by using Lat/ mice and the pLFG-C (line 3073) transgenic
mice (Abraham et al., 1991). Mice were housed under specific-pathogen-
free conditions and handled in accordance with French and European
directives.
Adoptive T Cell Transfer
33 106 CD4+ T cells were washed three times in PBS and injected i.v. into the
specified nonirradiated recipient mice. Spleens were recovered 6 to 8 weeks
after transfer, unless otherwise specified.
Flow Cytometry
Flow cytometry analysis was performed as described previously (Mingueneau
et al., 2008; Nunez-Cruz et al., 2003). Before staining, single-cell suspensions
were preincubated for 10 min on ice with the antibody 2.4G2 to block Fc recep-
tors. Cells were subsequently stained and analyzed on a FACS Canto II flow
cytometer with Diva software (Becton Dickinson). Data were analyzed with
FlowJo software (Tree Star).
Determination of Serum IgG1 and IgE Concentration
The concentration of IgG1 and IgE were determined as described (Nunez-Cruz
et al., 2003).
Cytokine Measurement
IL-4 and IL-2 production was measured as previously described (Archambaud
et al., 2009). For IFN-g production, CD4+ T cells were stimulated for 48 hr with
graded concentrations of CD3 antibodies in the presence of a fixed concentra-
tion (0.5 mg/ml) of CD28 antibody. The level of IFN-g contained in the superna-
tant was determined with a specific ELISA (R&D Systems).Biochemistry
Cells were resuspended in a volume of 200 ml and stimulated for 2 min at 37C
with biotinylated anti-CD3 (10 mg), biotinylated anti-CD4 (10 mg), and avidin
(14 mg). Control, unstimulated cells were incubated with avidin alone. After lysis
in TNE buffer (50 mM Tris, 1% Nonidet P-40, 20 mM EDTA) supplemented with
protease and phosphatase inhibitors, lysates were subjected to immunoblot
analysis. Antibodies against phosphotyrosine (9411), pY416-Src (2101), Lck
(2752), pY319-ZAP-70 (2701), p183-PLCg1, pS473-Akt (9271), ERK1-2,
pERK1-2, pY774-c-Cbl (3555) pGSK-3b (Ser9) (9336), and ZAP-70 (2705)
were purchased from Cell Signaling and those against pY128-SLP-76
(558367) were from BD Biosciences. Anti-LAT (sc-53550) and anti-PLCg1
(sc-81) were purchased from Santa Cruz Biotechnology Inc.
Calcium Flux Measurement
Cells were loaded with the calcium reporter Indo-1 (Molecular Probes) and
calcium responses monitored as described (Mingueneau et al., 2008). Base-
line fluorescence was recorded with an LSRI flow cytometer (Beckton Dickin-
son), and biotinylated CD33 antibody (145-2C11; BD PharMingen) added at
a final concentration of 5 mg/ml 1 min after starting data acquisition. Cross-link-
ing of the TCR-CD3 complexes was induced at t = 6 min by adding 10 mg/ml
streptavidin (Pierce). Calcium responses were analyzed with the Flowjo
kinetics platform.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and eight
figures and can be found with this article online at http://www.cell.com/
immunity/supplemental/S1074-7613(09)00322-7.
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